Cite

    Delvecchio, V. et al. (2020). Interleukin‐1 receptor‐associated kinase 4 inhibitor interrupts toll‐like receptor signalling and sensitizes chronic lymphocytic leukaemia cells to apoptosis. British journal of haematology. pp. 475-488. [Online].